NPM1 and acute myeloid leukemia: To determine, whether CEBPA dPM correlates with mutations frequently reported in AML we analyzed FLT3-ITD and MLL-PTD as well as mutations in NPM1, FLT3-TKD, RUNX1, ASXL1, DNMT3A, IDH1R132, IDH2R140, IDH2R172 and TET2 in correlation to CEBPA dPM status.